PRESS RELEASES

PRESS RELEASES

February 24, 2015
BELGRADE, Mont. , Feb. 24, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts, today announced that its CEO, Dan Goldberger , will present at the 27th Annual ROTH Conference to be held March 8th - 11th at The Ritz
February 17, 2015
BELGRADE, Mont. , Feb. 17, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and coatings for medical applications, today announced that it has eclipsed an operational milestone processing over 1000 lots of OsteoSelect
January 12, 2015
Fourth Quarter Total Revenue in the Range of $8.9 Million to $9.1 Million, an Increase of Approximately 8-10% Over the Same Period Last Year BELGRADE, Mont. , Jan. 12, 2015 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone
November 26, 2014
BELGRADE, Mont. , Nov. 26, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of revolutionary bone grafts and coatings for medical applications, today announced that its CFO, John Gandolfo , will present at the LD Micro Conference 7th Annual
November 14, 2014
BELGRADE, Mont. , Nov. 14, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE) today announced that the Company received notice that the staff of NYSE Regulation, Inc. has determined to commence proceedings to delist the Company's common stock from the NYSE MKT LLC ("NYSE
November 5, 2014
Company Increases Year-Over-Year Sales, Improves Margins and Reduces Loss From Operations Third Quarter Highlights: Third Quarter 2014 total revenue increased approximately 6.6% to $8.454 million from $7.930 million reported during the third quarter of 2013 Gross profit increased 17.9% to $5.436
November 5, 2014
BELGRADE, Mont. , Nov. 5, 2014 (GLOBE NEWSWIRE) -- Bacterin International Holdings, Inc. (NYSE MKT:BONE), a leader in the development of bone graft material and bioactive coatings for medical applications, today announced three senior additions to its Field Sales Organization .